| __timestamp | Pharming Group N.V. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 14182353 | 293000 |
| Thursday, January 1, 2015 | 15503028 | 1002000 |
| Friday, January 1, 2016 | 16183585 | 888000 |
| Sunday, January 1, 2017 | 22382849 | 19623000 |
| Monday, January 1, 2018 | 33038206 | 30421000 |
| Tuesday, January 1, 2019 | 31777040 | 34794000 |
| Wednesday, January 1, 2020 | 41464134 | 28304000 |
| Friday, January 1, 2021 | 67178053 | 56886000 |
| Saturday, January 1, 2022 | 52531000 | 100894000 |
| Sunday, January 1, 2023 | 68914000 | 159765000 |
Cracking the code
In the competitive world of pharmaceuticals, innovation is key. Over the past decade, Pharming Group N.V. and Viridian Therapeutics, Inc. have been at the forefront of this race. From 2014 to 2023, both companies have significantly increased their research and development (R&D) expenses, a testament to their commitment to innovation.
Pharming Group N.V. started with a modest investment in 2014, but by 2023, their R&D expenses had surged by nearly 385%. Meanwhile, Viridian Therapeutics, Inc. demonstrated an even more aggressive growth trajectory, with their R&D spending skyrocketing by over 54,000% during the same period. This dramatic increase highlights Viridian's strategic pivot towards innovation.
While both companies have shown impressive growth, Viridian's recent investments suggest a bold vision for the future. As the pharmaceutical landscape evolves, these investments could be pivotal in shaping the next wave of medical breakthroughs.
Research and Development: Comparing Key Metrics for Gilead Sciences, Inc. and Pharming Group N.V.
GSK plc vs Pharming Group N.V.: Strategic Focus on R&D Spending
Research and Development Investment: Biogen Inc. vs Viridian Therapeutics, Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Viridian Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Incyte Corporation and Viridian Therapeutics, Inc.
Research and Development Investment: Blueprint Medicines Corporation vs Viridian Therapeutics, Inc.
Pharming Group N.V. vs Opthea Limited: Strategic Focus on R&D Spending
Pharming Group N.V. or Verona Pharma plc: Who Invests More in Innovation?
Pharming Group N.V. or Protagonist Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for HUTCHMED (China) Limited and Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Taro Pharmaceutical Industries Ltd. or Viridian Therapeutics, Inc.: Who Invests More in Innovation?